Simplex Trading
RCUS icon

Simplex Trading’s Arcus Biosciences RCUS Stock Holding History

Simplex Trading’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$49.7K Sell
2,300
-400
-15% -$8.64K ﹤0.01% 5889
2025
Q4 		$64.3K Sell
2,700
-200
-7% -$4.08K ﹤0.01% 5418
2025
Q3 		$39K Sell
2,900
-3,300
-53% -$34.3K ﹤0.01% 6703
2025
Q2 		$50K Buy
6,200
+2,000
+48% +$17.1K ﹤0.01% 5922
2025
Q1 		$32K Buy
4,200
+3,200
+320% +$37.1K ﹤0.01% 6196
2024
Q4 		$14K Sell
1,000
-600
-38% -$9.8K ﹤0.01% 6966
2024
Q3 		$24K Buy
1,600
+700
+78% +$11K ﹤0.01% 6536
2024
Q2 		$13K Sell
900
-13,400
-94% -$216K ﹤0.01% 7261
2024
Q1 		$269K Sell
14,300
-59,200
-81% -$1.02M ﹤0.01% 4534
2023
Q4 		$1.4M Sell
73,500
-32,300
-31% -$516K ﹤0.01% 2679
2023
Q3 		$1.9M Sell
105,800
-39,800
-27% -$800K ﹤0.01% 2122
2023
Q2 		$2.96M Buy
145,600
+126,500
+662% +$2.41M ﹤0.01% 1664
2023
Q1 		$348K Buy
19,100
+3,500
+22% +$66.9K ﹤0.01% 3660
2022
Q4 		$322K Buy
15,600
+15,500
+15,500% +$427K ﹤0.01% 3654
2022
Q3 		$2K Sell
100
-30,800
-100% -$815K ﹤0.01% 9338
2022
Q2 		$783K Buy
30,900
+28,600
+1,243% +$700K ﹤0.01% 2904
2022
Q1 		$72K Buy
+2,300
New +$77.1K ﹤0.01% 6621
2021
Q4 		– Sell
-3,200
Closed -$88K – 11266
2021
Q3 		$88K Hold
3,200
– – ﹤0.01% 6805
2021
Q2 		$87K Buy
+3,200
New +$91.4K ﹤0.01% 6931
2020
Q4 		– Sell
-1
Closed -$1K – 8928
2020
Q3 		$1K Buy
+1
New +$22 ﹤0.01% 7588
2020
Q2 		– Sell
-6
Closed -$8K – 8221
2020
Q1 		$8K Buy
+6
New +$75 ﹤0.01% 6614
2019
Q4 		– Sell
-2
Closed -$1K – 7851
2019
Q3 		$1K Buy
+2
New +$16 ﹤0.01% 7067

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Simplex Trading's RCUS Position: Q4 2025 in Review

Simplex Trading sold out of Arcus Biosciences (RCUS) in Q4 2025, closing a stake of 105,025 shares — an estimated $2.14M sold.

Simplex Trading first reported a position in RCUS in Q3 2019 and held it in 16 quarters. The position peaked at $2.53M in Q2 2023. 209 funds tracked by Wall St. Rank hold RCUS as of Q4 2025.

  • Simplex Trading reported no remaining Arcus Biosciences position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 105,025 Arcus Biosciences shares in Q4 2025, an estimated $2.14M.
  • Simplex Trading first reported a position in Arcus Biosciences in Q3 2019 and held it in 16 quarters.
  • Simplex Trading's Arcus Biosciences position peaked at $2.53M in Q2 2023.
  • 209 funds tracked by Wall St. Rank held Arcus Biosciences as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.